These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 17584146)
1. Validated ligand binding sites in CCK receptors. next step: computer-aided design of novel CCK ligands. Tikhonova IG; Marco E; Lahlou-Archer E; Langer I; Foucaud M; Maigret B; Fourmy D Curr Top Med Chem; 2007; 7(12):1243-7. PubMed ID: 17584146 [TBL] [Abstract][Full Text] [Related]
2. Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies. Galés C; Poirot M; Taillefer J; Maigret B; Martinez J; Moroder L; Escrieut C; Pradayrol L; Fourmy D; Silvente-Poirot S Mol Pharmacol; 2003 May; 63(5):973-82. PubMed ID: 12695525 [TBL] [Abstract][Full Text] [Related]
3. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin. Gigoux V; Maigret B; Escrieut C; Silvente-Poirot S; Bouisson M; Fehrentz JA; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy AD Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537 [TBL] [Abstract][Full Text] [Related]
4. Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin. Foucaud M; Archer-Lahlou E; Marco E; Tikhonova IG; Maigret B; Escrieut C; Langer I; Fourmy D Regul Pept; 2008 Jan; 145(1-3):17-23. PubMed ID: 17961734 [TBL] [Abstract][Full Text] [Related]
5. Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonists. Fourmy D; Escrieut C; Archer E; Galès C; Gigoux V; Maigret B; Moroder L; Silvente-Poirot S; Martinez J; Fehrentz JA; Pradayrol L Pharmacol Toxicol; 2002 Dec; 91(6):313-20. PubMed ID: 12688374 [TBL] [Abstract][Full Text] [Related]
6. The family of G protein-coupled receptors: an example of membrane proteins. Tikhonova IG; Fourmy D Methods Mol Biol; 2010; 654():441-54. PubMed ID: 20665280 [TBL] [Abstract][Full Text] [Related]
7. Strategies for design of non peptide CCK1R agonist/antagonist ligands. García-López MT; González-Muñiz R; Martín-Martínez M; Herranz R Curr Top Med Chem; 2007; 7(12):1180-94. PubMed ID: 17584140 [TBL] [Abstract][Full Text] [Related]
8. Probing a model of a GPCR/ligand complex in an explicit membrane environment: the human cholecystokinin-1 receptor. Hénin J; Maigret B; Tarek M; Escrieut C; Fourmy D; Chipot C Biophys J; 2006 Feb; 90(4):1232-40. PubMed ID: 16326901 [TBL] [Abstract][Full Text] [Related]
10. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors. Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778 [TBL] [Abstract][Full Text] [Related]
11. Localization of cholecystokinin A and cholecystokinin B/gastrin receptors in the canine upper gastrointestinal tract. Mantyh CR; Pappas TN; Vigna SR Gastroenterology; 1994 Oct; 107(4):1019-30. PubMed ID: 7926455 [TBL] [Abstract][Full Text] [Related]
12. Design of novel cholecystokinin-B receptor ligands based on the 'double-ring system' approach. Lowe JA; Qian W; McLean S; Bryce DK; Crawford RT; Olsson LC; Bordner J Regul Pept; 1996 Aug; 65(1):11-4. PubMed ID: 8876030 [TBL] [Abstract][Full Text] [Related]
13. Modeled structure of a G-protein-coupled receptor: the cholecystokinin-1 receptor. Archer-Lahlou E; Tikhonova I; Escrieut C; Dufresne M; Seva C; Pradayrol L; Moroder L; Maigret B; Fourmy D J Med Chem; 2005 Jan; 48(1):180-91. PubMed ID: 15634012 [TBL] [Abstract][Full Text] [Related]